© 2026 Sinochem Nanjing Corporation,
All Right Reserved
Name: Daclatasvir Dihydrochloride
Chemical Formula: C40H52Cl2N8O6
Intended Use: Primarily used as an antiviral medication in the treatment of Hepatitis C. Recognizing this compound by its clinical role matters, because improper handling or accidental exposure impacts not just the worker, but can disrupt pharmaceutical integrity and safety across the supply chain.
Acute Toxicity: Based on current literature, daclatasvir dihydrochloride does not cause immediate severe toxicity at low levels, but the full effects of chronic or high-dose exposure have not been fully mapped out.
Health Hazards: Potential allergens and irritants can occur from powder inhalation, skin contact, or accidental ingestion. Lab experience tells us the minor symptoms — cough, sneezing, mild rash — easily get brushed off unless workers and supervisors stay watchful.
Environmental Hazards: Though it’s not flagged for acute aquatic toxicity, the cumulative impact in wastewater adds up, especially where pharmaceutical residues regularly enter the municipal system.
Main Ingredient: Daclatasvir dihydrochloride in pure or formulated form.
Impurities: Trace solvents left from manufacturing, but each lot may carry unique residuals depending on production quality. Usually, pharmaceutical-grade batches have well-controlled impurity profiles.
Inhalation: If powder becomes airborne, removing the victim to fresh air helps most of the time. Cough or shortness of breath needs medical attention, especially in workers with a history of asthma or allergies.
Skin Contact: Washing with soap and water removes residue. Even though gloves usually provide a barrier, double-checking for skin irritation after unintentional exposure helps avoid lingering health issues.
Eye Contact: Rinsing for several minutes under water is best. Experience teaches never to skip medical review even if symptoms seem mild at first.
Ingestion: Medical intervention is non-negotiable. Ingestion protocols always lean on caution, reflecting hard lessons learned from underestimating chronic toxicity in research settings.
Suitable Extinguishing Media: Water spray, foam, dry powder, or carbon dioxide, depending on the scale and available resources. Each fire scenario creates its challenges, but quick access to an ABC extinguisher remains non-optional in labs and transport spaces.
Specific Hazards: Combustion of organic pharmaceutical compounds often yields toxic fumes, including nitrogen oxides, carbon monoxide, and hydrochloric acid. No one in safety overlooks the need for full respiratory protection in post-blaze cleanup.
Firefighter Protection: Self-contained breathing apparatus and chemical protective clothing are essential. After years in research labs, I learned the hard way that even minor exposure to breakdown products can cause lasting symptoms.
Personal Precautions: Avoid direct contact through gloves, masks, and safety goggles. Use local exhaust or fume hoods for cleanup, turning to spill kits for containment as needed. Spills highlight the gap between standard procedures and real-world practices—training often prevents panic when every minute counts.
Methods for Cleaning Up: Careful sweeping, using wet methods when possible. Collected powder goes in sealed, labeled waste bags. Chronic underfunding in housekeeping too often leads to subpar spill management, risking cumulative exposure for whole teams.
Handling: Use powder-only under properly vented enclosures. Minimize dust generation and avoid open handling in non-designated areas. Using the right PPE ought to be standard, but sometimes corners get cut without strong management oversight.
Storage: Store in tightly closed containers, away from incompatible substances and moisture. A cool, dry, and dark place slows degradation, ensuring long-term stability and reducing risk in multicompound storerooms. Routine storage audits and training keep mistakes to a minimum.
Engineering Controls: Fume hoods, local exhaust, and HEPA filters best manage airborne exposure. On-site audits show that upgrades lag behind best practices unless upper management shapes policies around real-world feedback.
Personal Protection: Nitrile or latex gloves, safety goggles, long-sleeved lab coats. Respiratory protection, like disposable masks or half-face respirators, play a critical role in new drug development labs, especially when powders disperse invisibly.
Hygiene Measures: No food, drink, or smoking in handling areas. Hand-washing is not just recommended but enforced in the best-run facilities, cutting down on accidental transfer risk.
Appearance: White to off-white powder, no strong odor.
Solubility: Highly soluble in water, ethanol, and methanol.
Stability: Stays stable in dry, room-temperature conditions. Deteriorates if left exposed to light or high humidity.
Melting Point: Published data puts it above 200°C, fitting for a complex molecule with many fused rings.
pH: Aqueous solutions run on the acidic side due to the dihydrochloride groups.
Stability: Remains stable under recommended storage conditions. Experiences in warehouse environments highlight the risks of heat and direct sunlight, which speed up breakdown and create hazardous residues.
Reactivity: Sensitive to moisture and some strong oxidants. Staff responsible for handling hazardous materials use separate storage or clear labeling to avoid accidental mixing.
Decomposition Products: Breaks down into hydrochloric acid, nitrogen oxides, and smaller organic fragments, turning minor accidents into potential regulatory headaches.
Acute Effects: Animal studies and occupational reports indicate low acute oral and inhalation toxicity, but no medicine gets a free pass for cumulative risk.
Long-Term Exposure: Limited data in humans, but the general profile of antiviral agents suggests monitoring for liver and kidney function in those around raw compound for months or years.
Carcinogenicity, Mutagenicity, Reproductive Toxicity: So far, there’s no conclusive evidence, yet research culture steers away from complacency, since late-stage findings upset assumptions regularly in pharmaceutical safety history.
Persistence: Daclatasvir dihydrochloride likely resists rapid environmental breakdown. Treated wastewater sometimes carries detectable traces, sparking debate about long-term ecosystem effects, especially in urban rivers.
Bioaccumulation: No current evidence of bioaccumulation in fish or plants, though environmental regulators keep a close eye on emerging residues from new classes of drugs.
Mobility: Due to water solubility, the compound could migrate through soil and water under some conditions, leading environmental chemists to call for regular monitoring from production sites.
Waste Disposal: Treat as hazardous pharmaceutical waste—incineration or landfill according to local and national guidelines. My own work in university labs often revealed waste mislabeling, raising risks of cross-contamination and regulatory noncompliance.
Contaminated Packaging: Triple-rinsed before disposal, or processed as hazardous waste. In practice, waste stream audits catch more errors than any written protocol alone, helping refine waste management on the ground.
Packaging: Leak-proof, labeled, and internally cushioned containers ensure safe transit. Experience in logistics underscores the hard fact: a single shipment mishap creates chaos from warehouse to recipient, especially across international borders.
Classification: Most regulations do not categorize this compound as a dangerous good for road, rail, or air, but repeated incidents show that proper hazard communication is still key to avoiding handling errors in the field.
U.S. Regulation: Daclatasvir dihydrochloride receives oversight under FDA Good Manufacturing Practices. Drug manufacturing sites face routine inspections, and each batch gets audited before market release.
International Status: Across Europe and Asia, similar national agencies track compound import, handling, and disposal. Regulators adapt quickly as new studies update the safety profile, reflecting lessons from decades of pharmaceutical oversight.
Worker Protection Laws: Local occupational health and safety legislation applies. Real life in production and research spaces proves that beyond what's written, ongoing training and open communication keep people safe, particularly for novel and high-potency compounds.
